SCHEMBL245243

SCHEMBL245243

CCN(C)S(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL245936 0.77
SCHEMBL29011342 0.75
SCHEMBL14557426 0.73 CA1 (0.38)
N,N-Dimethylethanaminium SCHEMBL9789747 0.73 CA5A (0.43)
Propane SCHEMBL5572675 0.73 CA1 (0.38)
N,N-Dimethylethanaminium SCHEMBL9789750 0.73 CA5A (0.43)
SCHEMBL4565252 0.73
SCHEMBL3423329 0.73 MEN1 (0.32)
SCHEMBL241253 0.73 MEN1 (0.40)
N,N-Dimethylethanaminium SCHEMBL17385622 0.71 CA2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103911615-A Etching agent composition used for copper-contained metal DONGWOO FINE CHEM CO LTD 2014-07-09 CN claimed
US-12606464-B2 Membrane separation method KURITA WATER INDUSTRIES LTD. (JP) 2026-04-21 US disclosed
EP-4635610-A1 MEMBRANE TREATMENT METHOD AND BIOFOULING SUPPRESSION METHOD Kurita Water Industries Ltd. (JP) 2025-10-22 EP disclosed
US-12303833-B2 Reverse osmosis membrane treatment system and reverse osmosis membrane treatment method ORGANO CORPORATION (JP) 2025-05-20 US disclosed
CN-119032077-A Fluorescent compound, method for producing fluorescent compound, and water treatment agent composition 奥加诺株式会社 2024-11-26 CN disclosed
US-12083480-B2 Method for controlling slime in reverse osmosis membrane apparatus KURITA WATER INDUSTRIES LTD. (JP) 2024-09-10 US disclosed
WO-2024128050-A1 MEMBRANE TREATMENT METHOD AND BIOFOULING SUPPRESSION METHOD 栗田工業株式会社 2024-06-20 WO disclosed
US-20240083779-A1 METHOD FOR OPERATING REVERSE OSMOSIS MEMBRANE DEVICE, A SLIME CONTROL METHOD, AND A WATER TREATMENT DEVICE KURITA WATER INDUSTRIES LTD. (JP) 2024-03-14 US disclosed
US-11916195-B2 Electrolyte solution, electrochemical device, lithium ion secondary battery, and module DAIKIN INDUSTRIES, LTD. (JP) 2024-02-27 US disclosed
US-11916195-B2 Electrolyte solution, electrochemical device, lithium ion secondary battery, and module DAIKIN INDUSTRIES, LTD. (JP) 2024-02-27 US disclosed
US-6642223-B2 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2003-11-04 US disclosed
EP-1221440-A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators Otsuka Pharmaceutical Company, Limited (JP) 2002-07-10 EP disclosed
CN-1354787-A Process for purifying human papillomavirus virus-like particles MERCK & CO INC (US) 2002-06-19 CN disclosed
US-20020049194-A1 Benzoheterocyclic derivatives OGAWA HIDENORI (JP) 2002-04-25 US disclosed
US-6335327-B1 Benzoheterocyclic derivatives OTSUKA PHARMACEUTICALS CO., LTD. (JP) 2002-01-01 US disclosed
US-6096735-A Benzoheterocyclic derivatives OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 2000-08-01 US disclosed
EP-0765314-A1 BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-04-02 EP disclosed
WO-1995034540-A1 BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-12-21 WO disclosed
US-5128456-A Yellow to orange dyeings of cellulose fibers CIBA-GEIGY CORPORATION (US) 1992-07-07 US disclosed
US-4329282-A Fluoro-triazine-containing fibre-reactive disazo dyestuffs BAYER AKTEINGESELLSCHAFT (DE) 1982-05-11 US disclosed